Clinical Trials Directory

Trials / Unknown

UnknownNCT03435926

OCT and Microperimetry in Patients With Active Neovascular ARMD (CORFI)

Evaluating the Link Between Active Neovascularization Found on OCT and Eye Fixation Quality Measured With Microperimetry in ARMD Patients Treated With antiVEGF

Status
Unknown
Phase
Study type
Observational
Enrollment
110 (estimated)
Sponsor
University Hospital, Limoges · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

ARMD is the main cause of visual disability after 50 years old in France. Patients with active neovascular ARMD are treated with intravitreal injections of antiVEGF. Reinjections criteria are decrease of best corrected visual acuity or active neovascularization's signs (mostly found on macular OCT but also on angiography when necessary). The aim of this study is to evaluate the link between active neovascularization found on OCT and eye fixation quality measured with microperimetry in ARMD patients treated with antiVEGF. Quality of eye fixation and exudative signs presents or not present on OCT will be gathered at each consultation over the two-years follow-up for each patient. The mean central retinal sensitivity, the best corrected visual acuity and the bivariate contour ellipse area will also be gathered. In case no link will be found, for instance bad fixation quality without exudative signs on OCT or good fixation stability despite exudative signs on OCT, microperimetry should have an interest to improve reinjections criteria with a treatment more suitable to the patient.

Conditions

Timeline

Start date
2018-02-13
Primary completion
2021-02-13
Completion
2021-02-13
First posted
2018-02-19
Last updated
2019-01-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03435926. Inclusion in this directory is not an endorsement.